We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Sells

News List

Sofinnova sells Breath Therapeutics to Zambon in $550m deal pharmaceutical-technology
July 29, 2019
Venture capital firm Sofinnova Partners has dispossessed its portfolio company Breath Therapeutics to Italian pharmaceutical firm Zambon for a total consideration of up to $550m (€500m), including a €140m upfront payment.
Charity LifeArc sells rights to Keytruda for more than $1bn pharmaceutical-technology
May 22, 2019
UK-based medical research charity LifeArc has sold its royalty interest in Merck’s Keytruda (pembrolizumab) for $1.297bn to the European subsidiary of Canada Pension Plan Investment Board (CPPIB).
AstraZeneca Sells Infant Drug Rights for $1.5B contractpharma
November 14, 2018
AstraZeneca Sells Infant Drug Rights for $1.5B